Skip to content

King Pharmaceuticals KG Legacy Reinsurance — Total Assets

Similar metrics at other companies

Redwood Trust logo
RWTLegacy Investments — Total Assets
$945.02M-69.4%
Corebridge Financial logo
CRBGLegacy Life And Retirement Run Off Lines Segment Member — Reinsurance assets
$24.1B-3.2%
Array Technologies, Inc. logo
ARRYArray Legacy Operations — Segment assets
$1.27B+25.8%
Everest Group logo
EGLegacy — Incurred losses and LAE
$316M-22.4%
W.R. Berkley logo
WRBReinsurance & Monoline Excess — Total Assets
$5.78B+1.9%
Everest Group logo
EGLegacy — Premiums Written, Gross
$135M-80.3%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — total assets?
King Pharmaceuticals (KG) reported legacy reinsurance — total assets of $691.35M in Q1 2026.
What does legacy reinsurance — total assets mean?
The total value of economic resources controlled by the Legacy Reinsurance segment. This metric provides a baseline for assessing the scale and capital intensity of the segment's operations.